Search

Your search keyword '"Cohen, Mauricio G."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Cohen, Mauricio G." Remove constraint Author: "Cohen, Mauricio G." Topic myocardial infarction Remove constraint Topic: myocardial infarction
49 results on '"Cohen, Mauricio G."'

Search Results

1. Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registry.

2. Long-term outcomes among stable post-acute myocardial infarction patients living in rural versus urban areas: insights from the prospective, observational TIGRIS registry.

3. Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry.

4. 2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards.

5. Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registry.

6. Procedural Effectiveness With a Focused Force Scoring Angioplasty Catheter: Procedural and Clinical Outcomes From the Scoreflex NC Trial.

7. Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction.

8. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.

9. Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis.

10. Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarction.

11. Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries.

12. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry.

13. Culprit Vessel Only Versus Multivessel Percutaneous Coronary Intervention in Acute Myocardial Infarction with Cardiogenic Shock: A Systematic Review and Meta-Analysis.

14. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).

15. Coronary revascularization for acute myocardial infarction in the HIV population.

16. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.

17. Percutaneous Coronary Intervention: Relationship Between Procedural Volume and Outcomes.

18. Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States.

19. Aspiration Thrombectomy in Patients Undergoing Primary Angioplasty for ST Elevation Myocardial Infarction: An Updated Meta-Analysis.

20. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.

21. Differences in treatment patterns and outcomes between Hispanics and non-Hispanic Whites treated for ST-segment elevation myocardial infarction: results from the NCDR ACTION Registry-GWTG.

22. Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy.

23. Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program.

24. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction.

25. Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes.

27. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?).

28. Facilitated percutaneous coronary intervention in acute myocardial infarction: attractive concept but difficult to prove!

29. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.

30. Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction.

31. Electrocardiographic comparison of myocardial salvage with primary revascularization versus thrombolysis in inferior myocardial infarction.

33. AHA Scientific Statement: Mechanical Complications of Acute Myocardial Infarction A Scientific Statement from the American Heart Association

34. Fourth universal definition of myocardial infarction (2018)

35. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry

36. Management Strategies and Outcomes of ST‐Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States

37. Association between Public Reporting of Outcomes and the Use of Mechanical Circulatory Support in Patients with Cardiogenic Shock.

38. Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes.

39. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

40. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

41. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

42. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

43. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.

44. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.

45. Hospital Admissions for Chest Pain Associated with Cocaine Use in the United States.

46. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.

47. Racial Differences Among High-Risk Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes (Results from the SYNERGY Trial) † [†] Disclosure: Drs. Mahaffey, Cohen, Newby, Ferguson, and Califf have received honoria for speaking from sanofi-aventis. Drs. Mahaffey, Ferguson, and Califf have acted as consultants for sanofi-aventis. Drs. Echols, Velazquez, Santos, and Gurfinkel have no financial relationships to disclose.

48. USE OF EVIDENCE-BASED PREVENTIVE MEDICAL THERAPIES 1-3 YEARS POST-MYOCARDIAL INFARCTION IN THE PROSPECTIVE GLOBAL TIGRIS REGISTRY.

49. Ventricular Septal Defect Complicating ST-Elevation Myocardial Infarctions: A Call for Action.

Catalog

Books, media, physical & digital resources